Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-08-02 Sale | 2022-08-04 9:01 pm | Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner | 49,910 | $14.26 | $711,676 | 4,476,350 (Indirect Direct) | View |
2022-06-21 Sale | 2022-06-23 6:47 pm | Cullinan Oncology Inc. | CGEM | F2 Bioscience I 2017 Ltd Jovan-Embiricos Morana 10% Owner | 101,903 | $12.8 | $1,304,816 | 4,430,964 (Indirect Direct) | View |
2022-05-12 Sale | 2022-05-16 8:54 pm | Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner | 418,738 | $9.6619 | $4,045,791 | 4,532,867 (Indirect Direct) | View |
2021-11-10 Sale | 2021-11-15 5:17 pm | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director | 800 | $24.77 | $19,812 | 17,005,545 (Indirect Direct) | View |
2021-11-05 Sale | 2021-11-09 6:43 pm | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director | 12,196 | $24.8 | $302,455 | 17,005,665 (Indirect Direct) | View |
2021-10-27 Sale | 2021-10-29 5:02 pm | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director | 2,200 | $24.78 | $54,511 | 17,007,494 (Indirect Direct) | View |
2021-10-21 Sale | 2021-10-25 6:24 pm | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director | 13,592 | $24.8 | $337,045 | 17,007,824 (Indirect Direct) | View |
2021-01-12 Purchase | 2021-01-14 5:30 pm | Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner | 200,000 | $21 | $4,200,000 | 217,269 (Indirect Direct) | View |
2020-08-03 Purchase | 2020-08-06 06:06 am | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 2,900,000 | $17 | $49,300,000 | 2,830,197 (Indirect Direct) | View |
2019-12-18 Sale | 2019-12-20 5:31 pm | TCR2 THERAPEUTICS INC. | TCRR | Jovan-Embiricos Morana Globeways Holdings Ltd Globeways Holdings II Ltd F2 Capital I 2015 Ltd F2 Captial I 2017 Ltd F2 MG Ltd F2 Bioscience II 2017 Ltd F2 - TPO Investments LLC F2 BBG LLC F2 Capital I 2019 LLC 10% Owner | 44,856 | $16.51 | $740,387 | 1,885,246 (Indirect) | View |
2019-12-09 Sale | 2019-12-11 7:09 pm | TCR2 THERAPEUTICS INC. | TCRR | Jovan-Embiricos Morana Globeways Holdings Ltd Globeways Holdings II Ltd F2 Capital I 2015 Ltd F2 Captial I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC 10% Owner | 204,562 | $17.64 | $3,609,170 | 1,759,198 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-06 Option Award | 2024-06-07 4:05 pm | N/A N/A | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 35,000 | $0 | 26,603,054 (Direct) | View |
2023-05-11 Option Award | 2023-05-12 5:00 pm | N/A N/A | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 35,000 | $0 | 23,661,793 (Direct) | View |
2022-07-28 Option Award | 2022-08-01 4:35 pm | N/A N/A | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 8,152,247 | $4.61 | 16,704,963 (Indirect) | View |
2022-06-24 Exercise | 2022-06-28 9:24 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner | 140,374 | $4.3 | 4,526,260 (Direct) | View |
2022-06-24 Exercise | 2022-06-28 9:24 pm | N/A 2022-06-30 | Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner | 140,374 | $0 | 4,526,260 (Direct) | View |
2022-06-24 Tax Withholding | 2022-06-28 9:24 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner | 45,078 | $13.39 | 4,526,260 (Direct) | View |
2022-05-17 Option Award | 2022-05-19 4:28 pm | N/A 2032-05-16 | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 27,500 | $0 | 27,500 (Direct) | View |
2021-09-16 Option Award | 2022-03-25 7:32 pm | N/A 2031-09-15 | Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana Director | 7,800 | $0 | 7,800 (Direct) | View |
2022-01-11 Other | 2022-01-13 5:22 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner | 1,187,734 | $0 | 2,912,345 (Direct) | View |
2021-05-25 Option Award | 2021-05-27 4:45 pm | N/A 2031-05-24 | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 22,500 | $0 | 22,500 (Direct) | View |
2021-01-12 Conversion | 2021-01-14 5:30 pm | N/A N/A | Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner | 46,770,331 | $0 | 217,269 (Indirect) | View |
Ownership | 2021-01-07 8:32 pm | N/A N/A | Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC Director 10% Owner | 0 | $0 | 6,079,713 (Direct) | View |
2020-08-03 Conversion | 2020-08-06 06:06 am | N/A N/A | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 38,546,881 | $0 | 2,830,197 (Indirect) | View |
2020-07-29 Option Award | 2020-07-31 6:44 pm | N/A 2030-07-29 | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 22,500 | $0 | 22,500 (Direct) | View |
Ownership | 2020-07-30 07:35 am | N/A N/A | Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner | 0 | $0 | 15,509,595 (Direct) | View |
2019-12-20 Other | 2019-12-20 5:31 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Jovan-Embiricos Morana Globeways Holdings Ltd Globeways Holdings II Ltd F2 Capital I 2015 Ltd F2 Captial I 2017 Ltd F2 MG Ltd F2 Bioscience II 2017 Ltd F2 - TPO Investments LLC F2 BBG LLC F2 Capital I 2019 LLC 10% Owner | 600,000 | $0 | 1,885,246 (Indirect) | View |